Christopher Rose

Christopher Rose

Company: Genentech

Job title: Senior Scientist & Group Leader


Personalized Cancer Vaccines: Technologies to Screen Neoepitope Presentation 10:00 am

• Approaches to enhance presentation of epitopes from candidate neoantigens • A high throughput targeted mass spectrometry approach for sensitive detection neo-epitope presentation • Looking toward next generation protein sequencing technologies for neo-epitope discoveryRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.